WEBINARS
Rapid Process Development And Technical Support For AAV Scaleup
Accelerate your AAV production journey. Learn how rapid process development and expert support can streamline your path from vial to purified bulk, ensuring scalable and efficient manufacturing.
Advancing The Purification Of VSV-G Pseudotyped Lentiviral Vector
Discover new strategies to overcome lentiviral purification challenges with a scalable approach that maintains viral infectivity through gentle processing conditions.
A Successful Journey To Cell Therapy Manufacturing
Learn about the three main areas to consider when you're preparing to commercialize a cell therapy, including starting/raw material, the controlled manufacturing process, as well as testing safety and quality.
CHO Solutions Day Part 1
This CHO Solutions Day presentation offers valuable insights into new media and feed systems, a successful scale-up story, and how multi-omics analysis can enhance your cell culture.
Building A Purification Toolkit For An Expanding Variety Of mAb Therapeutics
Explore techniques for optimizing purification toolkits for various monoclonal antibody formats. This session covers resin and buffer selection for efficient downstream process development.
De-Risking Cell Culture Media Scale-Up For Late-Stage Manufacturing
Explore practical approaches to scaling cell culture media manufacturing, from supply assurance to evolving quality requirements, digital formulation tools, and strategies for controlling costs.
Beyond Standard Protein A Resin
In this study, mAbCapture C affinity resin has been compared with a Protein A resin used in a DSP platform, showing a higher dynamic binding capacity while keeping the product’s critical quality attributes within acceptable limits.
Rapid Micro Methods In QC Micro Testing: A NIBRT Perspective
Learn about some of the advanced Rapid Micro Method systems that are being adopted by biopharma companies worldwide, and how they are changing the face of QC Microbiological testing.
Development Of A CHO Medium And Feed System Using Advanced Analytical Tools And Workflow Considerations
Discover how multiomics analysis and optimized formulations in a new cell culture medium deliver higher protein titers and specific productivity for CHO fed-batch systems.
Advancing Gene Therapy Development With A Multi-Serotype AAV Resin
In this webinar, leading CDMO ABL and Thermo Fisher will share data on implementation of the POROS™ CaptureSelect™ AAVX affinity resin into such an AAV purification platform, including its performance in purifying several serotypes.
Leveraging dPCR r Techniques To Quantitate Lentivirus Particles
Discover how digital PCR can streamline lentiviral vector characterization to reduce variability and improve analytical sensitivity. Learn how this approach can help you comply with regulatory guidance.
The Way Forward: Supply Chain Solutions
Learn how to build a resilient supply chain to navigate today's complex environment. Expert speakers share insights on optimization, innovation, and strategic planning to meet evolving market conditions.
Driving Measurable Productivity Gains In CHO Cell Culture
Explore how targeted media supplementation can improve CHO cell culture outcomes, simplify process optimization, and increase productivity across monoclonal antibodies and emerging modalities.
CHO Solutions Day Part 2
Discover how to optimize your CHO process with key insights from CHO Solutions Day. Learn about the importance of tracking viable cell volume, using flexible media, and leveraging a harmonized manufacturing network.
Efficient AAV Purification With AAVx And AAV9 Magnetic Beads
Explore an alternative to chromatographic affinity capture that eliminates the need for universal nuclease treatment by utilizing magnetic beads with ligands specific to AAV.
Driving Sustainability In Bioprocessing With Biobased Single-Use Solutions
Discover how biobased materials in bioprocessing enable measurable carbon emission reductions. Learn practical strategies to meet decarbonization goals and adopt greener, operationally sound practices.
Next-Gen Disease Models And Cell Therapeutics: Innovations In AI, Omics And Collaboration
Learn how to leverage AI, omics integration, and collaborative research to build more physiologically relevant disease models and accelerate the development of next-gen cell therapies.
CAR-T Innovation: Balancing Allogeneic And Autologous Cell Therapy
Join experts as they discuss strategies for optimizing allogeneic and autologous therapies, aiming for balanced development and wider patient accessibility by 2030.
Enhancing AAV Purification In Gene Therapy Manufacturing
Review chromatography solutions for purifying multiple AAV serotypes, with specialists’ insights on bioprocessing and downstream optimization.
Innovative Strategies For Residual DNA And Viral Titre Quantitation
Discover how digital PCR improves the accuracy of residual host cell DNA and viral titre quantification in biotherapeutic manufacturing to enhance product quality, safety, and regulatory compliance.
Efficient Downstream Processing Of Antibody-Based Therapeutics – A CDMO Perspective
Discover efficient downstream processing strategies for antibody-based therapeutics. Explore key considerations and trade-offs in purity, yield, speed, and cost, from a CDMO perspective.
Manufacturing Friendly Aggregate Clearance In Downstream Processing
In this webinar, results are shared from the evaluation and preliminary optimization of a mixed-mode chromatography unit operation designed for aggregate removal in flow-through mode using a high-throughput POROS resin with immobilized caprylic acid.
Validation Of A qPCR Assay For Host Cell DNA Quantitation
Here, we share the development and validation of a new, highly sensitive and accurate integrated solution for detection and quantitation of host cell DNA to help meet regulatory requirements.
Defined Media, Defined Results: Scaling E. coli From Bench To Fermenter
Understand the benefits of chemically defined media in E. coli systems, explore real-world plasmid DNA data, and learn practical strategies for scaling to robust manufacturing.
Knowledge Culture: Downstream Innovation
In this workshop, you’ll learn about various solutions, from cell isolation to cell expansion, that can support autologous and allogeneic cell therapy process needs, digital automation, and mycoplasma testing.
Knowledge Culture Basics — Gene Therapy Education Series: Lentiviral Vectors
In this session of our ongoing education series on lentiviral vectors, we delve further into principles of lentiviral transduction and challenges in suspension-based lentivirus production.
mAb Up- And Downstream Process Intensification Strategies
Discover how to reduce monoclonal antibody (mAb) manufacturing time and costs through process intensification. Learn about continuous perfusion, ultrahigh cell density banks, and more.
Developing A 2-Step Chromatographic Process For The Purification Of AAV Vectors
POROS CaptureSelect AAVX and POROS 50 HQ were tested for capture and polishing, respectively, of AAV2, AAV9 and a novel engineered capsid to achieve vectors with high purity and significant empty: full ratio improvement.
Key Considerations For Rapid Microbial Methods For Mycoplasma Detection
Learn the importance of demonstrating product specific suitability, defining representative sample, consistent sampling protocols, accommodating volume and turnaround time constraints, and the need to establish equivalence.
CAR-T Strategy In 2026: Scaling Autologous, Advancing Allogeneic
As CAR-T advances, shifting clinical progress and market dynamics are reshaping development strategies. Explore how evolving therapies and operational demands are redefining the next wave of innovation.